Poolbeg Pharma #POLB August 2023 – CEO Jeremy Skillington talks to Alan Green August 7, 2023 – Posted in: Blog, Poolbeg Pharma (POLB)

Poolbeg CEO Jeremy Skillington talks to Alan Green in this August 2023 interview, and explains the company’s ‘capital light’ model that is giving the group a real market advantage. Jeremy then covers the developments this year with Poolbeg’s flagship POLB001 asset towards a blockbuster treatment for severe influenza, and the expansion of application into oncology and obesity. We then discuss joint ventures with AnaBio Technologies in the EncOVac consortium and the Cytoreason AI collaboration, before…

Continue reading

Power In The Community – Alan Green talks to Paysme CEO Derek Stewart January 12, 2023 – Posted in: Blog

Paysme’s mission is powering the first FinTech Super App championing underserved small business communities to accelerate their transition to a growing digital economy & unlocking their full potential. Alan Green talks to CEO Derek Stewart about the journey to develop the company, and his mission to help our community of small business customers take control of their finances. The opportunity and scale is almost limitless: Derek talks about the Paysme Black Cab app, the Marketti business…

Continue reading

A landmark year for Poolbeg Pharma #POLB – Alan Green talks to CEO Jeremy Skillington July 29, 2022 – Posted in: Blog, Poolbeg Pharma (POLB)

A landmark year for Poolbeg Pharma #POLB – Alan Green talks to CEO Jeremy Skillington, who takes us through what has been a very eventful year since the IPO. At 01:58 we discuss the flagship asset POLB 001, which reached a major milestone last week as it commenced a human challenge trial. At 05:00 Jeremy provides an overview of two collaborations in Artificial Intelligence and how Poolbeg will use these pioneering approaches to identify new treatments for…

Continue reading

Poolbeg Pharma #POLB – Exec Chairman Cathal Friel & CEO Jeremy Skillington talk to Alan Green November 9, 2021 – Posted in: Blog, Open Orphan (ORPH), Poolbeg Pharma (POLB)

Poolbeg Pharma #POLB Exec Chairman Cathal Friel and CEO Jeremy Skillington talk to Alan Green about the company’s ‘capital light’ business model. We discuss the POLB 001 asset, spun out of Open Orphan #ORPH, data samples, the PredictViral and vaccine discovery platforms plus further pipeline products. Cathal discusses the company cash position, and Jeremy highlights the upcoming value inflection points for investors and shareholders.

Continue reading
coin

Coinsilium Group Limited #COIN – Strategic Investment in Greengage Completed September 8, 2021 – Posted in: Blog, Coinsilium (COIN)

London, UK, 8 September 2021 — Coinsilium Group Limited (AQSE:COIN) (OTCQB:CINGF), the Blockchain and Open Finance venture builder is pleased to report that, further to its announcement on 20 August 2021, the Company has now completed the proposed transaction (the “Transaction”) with Greengage Global Holding Ltd (“Greengage”), a UK registered company which plans to become the first merchant bank for the digital finance sector via its wholly owned Gibraltar subsidiary Greengage & Co. Ltd. Greengage…

Continue reading
POLB

Poolbeg Pharma #POLB – POLB001 US Patent Update September 7, 2021 – Posted in: Blog, Poolbeg Pharma (POLB)

7 September 2021 – Poolbeg Pharma (AIM: POLB), ‘Poolbeg’ or the ‘Company’, a clinical stage infectious disease pharmaceutical company with a capital light clinical model, provides an update on the strengthening of its intellectual property (IP) position around lead product, POLB 001, a small molecule immunomodulator for the treatment of severe influenza. As detailed in the Admission Document, Poolbeg has a worldwide license for POLB 001 and is developing a strong IP portfolio with patent…

Continue reading

Saving Through Innovation – Alan Green talks to Tony Crawley, CEO at newly listed Zenova Group #ZED July 19, 2021 – Posted in: Blog, Zenova Group Plc (ZED)

Alan Green talks to Tony Crawley, CEO at newly listed Zenova Group (AIM: ZED) about the company’s range of innovative paints and coverings that provide protection against fire. Tony and Alan view part of one of the demo video clips on the Zenova Group website (https://zenovagroup.com/) that show the incredible fire resistant properties of Zenova paints, before Tony discusses the company’s plans for sales and distribution. Tony then talks about the company IPO, and gives…

Continue reading

NFT Vision Hack – Alan Green talks to Coinsilium (AQX: COIN, OTCQB: CINGF) CEO Eddy Travia July 14, 2021 – Posted in: Blog, Coinsilium (COIN)

Alan Green talks to Eddy Travia, CEO & Co-Founder of Coinsilium (AQX: #COIN, OTCQB: $CINGF), a Blockchain & Open Finance venture builder based in Gilbratar. Eddy talks about his role in the evolution of Coinsilium from the first ever blockchain IPO on the Aquis market, through to the move to Gilbraltar and last year’s pivot to become a venture builder in the blockchain and Non Fungible Token space. We look at the Nifty Labs JV…

Continue reading

Graphite at Orom Cross. Alan Green talks to Blencowe Resources #BRES Mike Ralston May 24, 2021 – Posted in: Blog

Brand Comms CEO Alan Green catches up once again with Blencowe Resources #BRES CEO Mike Ralston. Mike provides a background on the latest developments at the company’s 100% owned Orom Cross Graphite project in Uganda. We look at the preliminary assay metallurgy test results, before Mike updates on the fully funded Phase 2 drilling campaign. Mike looks at how the growth in the lithium ion battery and EV market is driving demand for graphite, before…

Continue reading